TUESDAY, Oct. 1, 2019 — Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older, the U.S. Food and Drug Administration announced Friday. The agency noted that pediatric patients with GPA, previously known as… Read More »
Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomised controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology (ESC). “Adhering to a… Read More »
Under the threat of financial penalty, hospitals are always on the lookout for ways to reduce their 30-day readmissions. For heart attack patients in particular,conducting a simple mobility test might be the best means of forecasting which patients are likely to return. Close to 20 percent of elderly adults who have suffered a heart attack… Read More »
Rachel Sawyer, a communications manager who is 50 and lives in Anerley in south east London, was diagnosed with Crohn’s disease in 2000 and treated at Guy’s and St Thomas’. Although her condition is now under control, she supports other people who have Crohn’s and runs the Twitter account @Bottomline_IBD. She said: “One of the worst… Read More »